Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 401 participants.

Also called NCT01165684

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 401 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01165684
  • EudraCT 2010-018974-19
Main results
  • Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial The lancet. Diabetes & endocrinology, 2014-01 DOI, PubMed 24622667

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Brazil, Canada, France, North Macedonia, Slovenia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01165684. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2012-04 (actual). Results posted on 2013-06-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
Acronym
Full STEP™
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
insulin aspart
Intervention (Drug)
insulin aspart
Intervention (Drug)
insulin detemir
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01165684
Content hash
a1736e0ff726d1c5255e5e662724f63c47fa27d8adbc4b02e1d74529c2c87ae1